Join Joanna Shields, CEO BenevolentAI, Robert Nelsen, Co-Founder & Managing Director, ARCH Venture Partners and Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation at The Forbes Healthcare Summit for a panel on How Smart Is Artificial Intelligence
Join Mark Davies at Global Engage congress on pharmaceuticals research & development. Mark Davies will present on how Artificial Intelligence (AI) is disrupting drug discovery.
Join Jackie Hunter at the Endpoints London Biotech Summit for a discussion on ROI and Innovation in drug development: What are the big and little biopharmas doing to change the equation?
Join Marwin Segler, Lead Machine Learning Researcher at Elrig event on Drug Discovery for Small & Large Molecules
This September, Marc Davies, VP Biomedical Informatics will be presenting at the Artificial Intelligence in Drug Development Congress on how machine learning technologies are changing how new medicines are discovered and developed.
Join Mark Rackham, Drug discovery scientist at BenevolentAI for a panel discussion on Precision Medicine and Biomarker Discovery
Join Nasrin Mostafazadeh at the NLP Seminar Series organised at Stanford University on the 30 November
VIDEO Jackie Hunter, CEO BenevolentBio is giving a talk at Web Summit 2017 on how Artificial Intelligence is revolutionising the methods in drug development.